GlassScriptPhysician profile
Michele Gallo
NPI 1548991300
$4,343.31
in general payments reported to CMS, 2019-2025
33 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $131 · 2023: $611 · 2024: $3,230 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,201 · Travel and Lodging: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,201.04 |
| Travel and Lodging | $1,011.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,968.61 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Konect Resilia |
| Medtronic, INC. | $518.90 | 2024 | Corevalve Evolut R, Onyx Frontier, Penditure |
| Atricure, INC. | $388.60 | 2022-2024 | |
| Teleflex LLC | $226.41 | 2023-2025 | Manta, Quikclot, Spectre |
| Boston Scientific Corporation | $149.05 | 2024-2025 | Avvigo Guidance System, Watchman Flx |
| Kls-Martin L.P. | $117.25 | 2023-2025 | |
| Getinge USA Sales, LLC | $89.09 | 2022-2025 | Cardiohelp, Vasoview Hemopro 2 |
| Actelion Pharmaceuticals US, INC. | $71.50 | 2023-2025 | Uptravi, Opsumit |
| Pfizer INC. | $69.68 | 2023-2025 | |
| Csl Behring | $64.37 | 2023-2024 | Kcentra |
| Stryker Corporation | $58.17 | 2023 | Spy-Phi System |
| Kestra Medical Technology Services, INC. | $55.25 | 2024 | Assure Wcd |
| Smith+Nephew, INC. | $48.42 | 2023-2024 | Renasys Touch, Pico 7, Pico 14 |
| Lsi Solutions INC | $46.26 | 2022-2024 | Cor-Knot |
| Novartis Pharmaceuticals Corporation | $46.06 | 2024-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Surgical LLC | $41.91 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $34.83 | 2025 | Wainua |
| Corcym INC | $34.37 | 2024-2025 | Perceval |
| Dilon Technologies, INC. | $29.07 | 2023 | Hemoblast Bellows |
| Angiodynamics, INC. | $26.00 | 2023 | Angiovac |
| Monaghan Medical Corporation | $25.78 | 2025 | Aerobika |
| Amgen INC. | $25.71 | 2024 | |
| Davol INC. | $25.22 | 2023 | Arista Ah Flexitip |
| Terumo Medical Corporation | $24.46 | 2023 | Azur Cx Detachable |
| Cvrx, INC. | $21.56 | 2023 | Barostim Neo System |
| Cerus Corporation | $20.77 | 2023 | Intercept Blood System For Platelets |
| La Jolla Pharmaceutical Company | $20.74 | 2023 | Giapreza |
| Alnylam Pharmaceuticals INC. | $18.67 | 2022 | |
| Livanova USA, INC. | $17.17 | 2022 | |
| Abiomed | $15.76 | 2025 | |
| Zimmer Biomet Holdings, INC. | $15.63 | 2025 | Sternalock Blu System |
| Baxter Healthcare | $14.04 | 2025 | Perclot |
| Biomerieux INC | $14.00 | 2024 | Vidas Nephrocheck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Gallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.